Roche Drug Patent Portfolio
Roche owns 4 orange book drugs protected by 11 US patents Given below is the list of Roche's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5763483 | Carbocyclic compounds | 27 Jun, 2017 | Expired |
| US5763483 | Carbocyclic compounds | 27 Dec, 2016 | Expired |
| US5952340 | Use of granisetron for the treatment of postoperative nausea and vomiting | 14 Sep, 2016 | Expired |
| US5866601 | Carbocyclic compounds | 02 Aug, 2016 | Expired |
| US5866601 | Carbocyclic compounds | 02 Feb, 2016 | Expired |
| US5952375 | Compounds and methods for synthesis and therapy | 27 Aug, 2015 | Expired |
| US6475491 | Treatment of HIV and other viral infections using combinatorial therapy | 07 Jun, 2015 | Expired |
| US5952375 | Compounds and methods for synthesis and therapy | 27 Feb, 2015 | Expired |
| US6133418 | Synthetic peptide inhibitors of HIV transmission | 17 Nov, 2014 | Expired |
| US5662918 | Pharmaceutical agents containing diphosphonic acids and salts thereof | 02 Sep, 2014 | Expired |
| US5464933 | Synthetic peptide inhibitors of HIV transmission | 07 Jun, 2013 | Expired |
Latest Legal Activities on Roche's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Roche.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 22 Apr, 2019 | US7192938 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 05 Nov, 2018 | US7192938 (Litigated) |
|
Expire Patent
Critical
| 18 Jun, 2018 | US7718634 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 01 Jan, 2018 | US7718634 (Litigated) |
|
Expire Patent
Critical
| 09 Sep, 2016 | US7410957 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 18 May, 2010 | US7718634 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 18 May, 2010 | US7718634 (Litigated) |
|
Issue Notification Mailed
Critical
| 28 Apr, 2010 | US7718634 (Litigated) |
| Dispatch to FDC | 14 Apr, 2010 | US7718634 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 14 Apr, 2010 | US7718634 (Litigated) |
|
Issue Fee Payment Received
Critical
| 01 Apr, 2010 | US7718634 (Litigated) |
|
Issue Fee Payment Verified
Critical
| 01 Apr, 2010 | US7718634 (Litigated) |
| Mail Miscellaneous Communication to Applicant | 01 Apr, 2010 | US7718634 (Litigated) |
| Miscellaneous Communication to Applicant - No Action Count | 29 Mar, 2010 | US7718634 (Litigated) |
|
Information Disclosure Statement considered
Critical
| 25 Mar, 2010 | US7718634 (Litigated) |
Roche's Drug Patent Litigations
Roche's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Apr 23, 1999, against patent number US5464933. The petitioner , challenged the validity of this patent, with BOLOGNESI as the respondent. Click below to track the latest information on how companies are challenging Roche's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US5464933 | April, 1999 |
Decision
(23 Apr, 1999)
| BOLOGNESI | |
Roche's Family Patents
Roche Drug List
Given below is the complete list of Roche's drugs and the patents protecting them.
1. Boniva
Boniva is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5662918 | Pharmaceutical agents containing diphosphonic acids and salts thereof |
02 Sep, 2014
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Boniva's drug page
2. Fuzeon
Fuzeon is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6475491 | Treatment of HIV and other viral infections using combinatorial therapy |
07 Jun, 2015
(9 years ago)
| Expired |
| US6133418 | Synthetic peptide inhibitors of HIV transmission |
17 Nov, 2014
(10 years ago)
| Expired |
| US5464933 | Synthetic peptide inhibitors of HIV transmission |
07 Jun, 2013
(11 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fuzeon's drug page
3. Kytril
Kytril is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5952340 | Use of granisetron for the treatment of postoperative nausea and vomiting |
14 Sep, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kytril's drug page
4. Tamiflu
Tamiflu is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5763483
(Pediatric)
| Carbocyclic compounds |
27 Jun, 2017
(7 years ago)
| Expired |
| US5763483 | Carbocyclic compounds |
27 Dec, 2016
(7 years ago)
| Expired |
| US5866601
(Pediatric)
| Carbocyclic compounds |
02 Aug, 2016
(8 years ago)
| Expired |
| US5866601 | Carbocyclic compounds |
02 Feb, 2016
(8 years ago)
| Expired |
| US5952375
(Pediatric)
| Compounds and methods for synthesis and therapy |
27 Aug, 2015
(9 years ago)
| Expired |
| US5952375 | Compounds and methods for synthesis and therapy |
27 Feb, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tamiflu's drug page